The landscape of Canadian health sciences received a monumental boost as the Ontario Bioscience Innovation Organization (OBIO) announced that enterprises…
Read More
The biotech bi-weekly: a disease modeling research grant and an accelerator program for data-driven health start-ups
The biotech sector continues its rapid evolution, marked this week by advancements poised to streamline laboratory processes, democratize powerful AI…
Read More
Seven Pharma Companies Selected for FDA PreCheck Pilot Program to Bolster U.S. Drug Supply Chain
The U.S. Food and Drug Administration (FDA) has announced the initial cohort of seven pharmaceutical companies selected to participate in…
Read More
The Secrets of Cognitive Resilience and the Neurobiology of Aging: A Twenty-Five Year Retrospective on the Northwestern SuperAging Program
For more than a quarter of a century, a dedicated cohort of researchers at Northwestern Medicine has been investigating a…
Read More
Cellular Intelligence Licenses Novo Nordisk’s Parkinson’s Cell Therapy Program Following Company’s Strategic Pivot
Seven months after Danish pharmaceutical giant Novo Nordisk officially shuttered its dedicated cell therapy unit in October 2025, a significant…
Read More
Northwestern University SuperAging Program Reveals Secrets of Cognitive Resilience and the Neurobiology of Exceptional Memory in Older Adults
For over a quarter of a century, a dedicated cohort of researchers at Northwestern Medicine has been investigating a demographic…
Read More
US Government Assumes Full Cost of Weight Loss Drugs for Medicare Beneficiaries Through Extended GLP-1 Bridge Program Amidst Insurer Hesitation
The Centers for Medicare & Medicaid Services (CMS) has announced a significant extension of its Medicare GLP-1 Bridge program, shifting…
Read More
FDA Proposes Permanent Authorization of Rare Pediatric Disease Priority Review Voucher Program to Foster Regulatory Stability
The United States Food and Drug Administration (FDA) is making a significant move to permanently authorize the rare pediatric disease…
Read More
The US Food and Drug Administration Convenes Public Hearing Amidst Scrutiny of Commissioner’s National Priority Voucher Program
The US Food and Drug Administration (FDA) is set to convene a significant public hearing on June 12, 2026, a…
Read More
